Prostate cancer vaccine (NewLink Genetics)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameProstate cancer vaccine (NewLink Genetics)
Drug Alias NameHyperAcute Prostate
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNewlink Genetics Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNewlink Genetics Co
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A